# Eupraxia Pharmaceuticals Inc.: Form 6-K, filed May 29, 2026

- Company: [Eupraxia Pharmaceuticals Inc.](/companies/eprx.md) (CIK 1581178)
- Form: 6-K
- Filed: 2026-05-29
- Accepted by EDGAR: May 29, 2026, 14:09 ET
- Period: 2026-05-28
- Accession: 0001171843-26-003785
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1581178/000117184326003785/f6k_052826mailing.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1581178/000117184326003785/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1581178/000117184326003785/f6k_052826mailing.htm

Filed May 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-003785. Last ingested by Listed: Nov 11, 2026, 03:36 ET. No prices; not investment advice.